Searched for
COVOVAX INDIA LAUNCH
DCGI panel to review SII applications for Covovax's use among kids aged 2-7 years, 7-11 yearsDrugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28 and in th...
Adar Poonawalla blames government for delay in launch of his vaccine Covovax"In Delhi over the last three months, what we are seeing is that we have gone back to the what I would say usual, normal processes business...
NTAGI's Covid working group to review SII's Covovax data for use in 12 year olds and aboveIndia's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years a...
India must use more vaccines in drive, allow boosters to those willing: Experts"Data shows that in people who have taken Covishield, the protein vaccine Covovax works better as a booster than another dose of Covishield...
WHO nod boosts Covovax chances of getting approval in IndiaCovovax is being manufactured in India by the Serum Institute of India (SII).
Covovax nod expected by January, data to be submitted soon, says SII ChiefThe drug regulator had earlier asked the company - which had applied for emergency use authorisation (SII) for Covovax in August - to submi...
Novavax to apply for emergency use authorisation (EUA) of Covid shot in the US before year endPune-based Serum Institute of India (SII) had applied to the Indian drug regulator in August for EUA for the launch of Covovax. However, it...
Serum Institute may face delay in Covovax launchIndia’s drug regulator has asked for the immunogenicity data from Serum Institute as the vaccine is not yet appoved by the US FDA.
Serum seeks nod for Covovax, J&J for its single-dose vaccineJohnson and Johnson (J&J) and Pune-based Serum Institute of India (SII) have applied to the drug regulator seeking emergency use authorisat...
Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEOHe also thanked the government for all the support provided to Serum Institute and said the company is always trying to expand its Covishie...
Serum Institute manufacturing first batch of Covovax COVID-19 vaccine, says Adar PoonawallaIn March this year, Poonawalla had said that the clinical trials of Covovax vaccine have begun in India and the company hopes to launch it ...
Novavax and the recombinant protein vaccine: What you need to knowThe recombinant protein vaccine develops the body’s immunity against the coronavirus by using the virus' spike proteins. Used by Novavax in...
SII aims to launch Covovax by September as US eases suppliesThe Pune-based vaccine maker has received the first lot of supplies of key raw materials for Covovax production, company insiders told ET. ...
Serum’s launch of Novavax shot in India may face delayAdar Poonawalla had complained in the past that the manufacturing of the Novavax vaccine was getting delayed due to a shortage of raw mater...
Covovax trials begin in India, hope to launch it by Sept 2021: Adar PoonawallaIn August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation ...
Serum Institute of India plans to launch Covovax by June: Adar PoonawallaSII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We...
Serum Institute applies for trials of another Covid vaccine- CovovaxThe country launched its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world's largest ino...